Amylyx Pharmaceuticals, Inc.AMLXNASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank83
Studio
Year-over-Year Change

Year-over-year operating income growth rate

Percentile
P83
Within normal range
vs 2Y Ago
0.4x
Contraction
Streak
1 yr
Consecutive growthAccelerating
PeriodValue
202551.29%
2024-911.12%
2023119.27%
2022-143.49%
2021-111.99%
2020-187.77%
20190.00%